A Survey of Physician and Molecular Tumor Board Perspectives on the Clinical Utility and Usability of Cellworks Singula™ and Ventura™ Reports in Facilitating Patient Treatment Decisions for Pan-Cancer Patients

NCT05308784 · clinicaltrials.gov ↗

UNKNOWN

Status

730

Enrollment

OTHER

Sponsor class

Conditions

Pan-cancer

Interventions

OTHER: Cellworks Singula and Ventura reports

Sponsor

Avera McKennan Hospital & University Health Center

Collaborators

[object Object]